Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C15H17N3O3 |
| Molecular Weight | 287.3138 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=CC=C(C=C1)C2=NN(CCCC(O)=O)C(=N)C=C2
InChI
InChIKey=ACVGNKYJVGNLIL-UHFFFAOYSA-N
InChI=1S/C15H17N3O3/c1-21-12-6-4-11(5-7-12)13-8-9-14(16)18(17-13)10-2-3-15(19)20/h4-9,16H,2-3,10H2,1H3,(H,19,20)
| Molecular Formula | C15H17N3O3 |
| Molecular Weight | 287.3138 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/8987785
Sources: https://www.ncbi.nlm.nih.gov/pubmed/8987785
Gabazine (SR-95531) is a selective GABAA receptors antagonist, which does not have any role in medicine, but is used in scientific experiments as the allosteric inhibitor of channel opening for the GABAA receptor.
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: CHEMBL2093872 Sources: https://www.ncbi.nlm.nih.gov/pubmed/17419756 |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
PubMed
| Title | Date | PubMed |
|---|---|---|
| Dopamine inhibition of glycine release in the rat trigeminal nucleus pars caudalis: possible involvement of trace amine receptors. | 2010-09 |
|
| An approach for reliably investigating hippocampal sharp wave-ripples in vitro. | 2009-09-07 |
|
| Novel mGluR- and CB1R-independent suppression of GABA release caused by a contaminant of the group I metabotropic glutamate receptor agonist, DHPG. | 2009-07-01 |
|
| GluK2-mediated excitability within the superficial layers of the entorhinal cortex. | 2009 |
|
| Agonist-, antagonist-, and benzodiazepine-induced structural changes in the alpha1 Met113-Leu132 region of the GABAA receptor. | 2007-02 |
|
| Presynaptic GABAA receptors facilitate spontaneous glutamate release from presynaptic terminals on mechanically dissociated rat CA3 pyramidal neurons. | 2006 |
|
| Sprouting of mossy fibers and presynaptic inhibition by group II metabotropic glutamate receptors in pilocarpine-treated rat hippocampal slice cultures. | 2005 |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/16420421
Neonatal and 21-day-old (P21) rats: P3 rat pups were anaesthetized and a syringe containing 0.5 μl of 0.9 % saline with 2.2 μCi of 3[H]Gabazine was inserted intrathecally. The compound was injected and 10min post injection the animals were terminally anaesthetized with sodium pentobarbitone. Injections of 3H-gabazine in the L4-L5 region at P3 confirmed that gabazine binding was restricted to the lumbar spinal cord. The effects of spinalization were consistent with gabazine facilitation of ventral root potentials observed in isolated neonatal spinal cord.
Route of Administration:
Other
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/11850512
Gabazine totally blocked evoked inhibitory postsynaptic currents (IPSCs) in CA3 pyramidal cells. The application of guanidinoethanesulfonic acid, an uptake inhibitor of beta-alanine and taurine, induced strychnine-sensitive chloride current in the presence of gabazine. To determine whether glycine receptors, which are expressed most strongly on CA3 pyramidal cells, are involved in synaptic transmission, it was characterized the pharmacological profile of the receptors mediating IPSCs evoked by brief extracellular stimulation (100 μs, single current pulse up to 30 μA) in the stratum radiatum of the CA3 region in the presence of CNQX (40 μm), CPP (40 μm) and CGP 62349 (5 μm). First, the sensitivity of the IPSC to GABAA receptor blockade by gabazine was tested. Evoked IPSCs and responses to GABA puffs were alternately induced. The degree of GABAA receptor blockade was monitored by examining the effect of gabazine on responses induced by GABA puffs, whose peak amplitudes were adjusted to match those of the alternately evoked IPSCs. Bath application of gabazine (10 μm) completely blocked the IPSC and inhibited the GABA-induced currents by 98.7 ± 0.3 % (n = 7). Application of gabazine also abolished spontaneous IPSCs. The incomplete blockade of responses to exogenous GABA by the competitive antagonist gabazine probably reflects the prolonged presence of GABA resulting from the puff applications, which may saturate GABA transporters, since even with the addition of gabazine to the GABA application pipette, GABA-induced currents could not be blocked completely.
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 22:21:17 GMT 2025
by
admin
on
Mon Mar 31 22:21:17 GMT 2025
|
| Record UNII |
L45297DIU1
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
L45297DIU1
Created by
admin on Mon Mar 31 22:21:17 GMT 2025 , Edited by admin on Mon Mar 31 22:21:17 GMT 2025
|
PRIMARY | |||
|
105538-73-6
Created by
admin on Mon Mar 31 22:21:17 GMT 2025 , Edited by admin on Mon Mar 31 22:21:17 GMT 2025
|
PRIMARY | |||
|
107896
Created by
admin on Mon Mar 31 22:21:17 GMT 2025 , Edited by admin on Mon Mar 31 22:21:17 GMT 2025
|
PRIMARY | |||
|
DTXSID20276043
Created by
admin on Mon Mar 31 22:21:17 GMT 2025 , Edited by admin on Mon Mar 31 22:21:17 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
SALT/SOLVATE -> PARENT |